Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Primary Research, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

6/17/2021
Press Release
Phoenix, Knoxville, Kansas City Stand Out for Retinal Treatment Opportunity in the US
Phoenix, Knoxville, Kansas City Stand Out for Retinal Treatment Opportunity in the US

The Phoenix metro area has the highest number of vitrectomies per provider in the US, while Knoxville, Tennessee, stands out for above average annual intravitreal injection volumes per provider. Ka...

6/18/2021
BreakingClinical TrialGene TherapyRetina
Biogen’s Choroideremia Candidate Fails to Meet Phase III Endpoints; News Follows Disappointing XLRP Trial Results
Biogen’s Choroideremia Candidate Fails to Meet Phase III Endpoints; News Follows Disappointing XLRP Trial Results

Biogen announced June 14 that its gene therapy candidate for choroideremia, timrepigene emparvovec (BIIB111/AAV2-REP1), had failed to meet primary and key secondary endpoints in the Phase III STAR ...

6/18/2021
BreakingCataractIOLSurgical
J&J Vision Launches TECNIS Eyhance Toric II in Europe
J&J Vision Launches TECNIS Eyhance Toric II in Europe

Johnson & Johnson Vision’s surgical unit announced June 8 that it had begun the European launch of its TECNIS Eyhance Toric II IOL, with the TECNIS Simplicity Delivery System. The company describes...

6/18/2021
BreakingClinical TrialGene TherapyRetina
Nanoscope Says its Optogenetic Gene Therapy Restores Clinically Meaningful Vision in 11 RP Patients
Nanoscope Says its Optogenetic Gene Therapy Restores Clinically Meaningful Vision in 11 RP Patients

Nanoscope Therapeutics reported June 3 that vision improvements for all evaluated advanced retinitis pigmentosa (RP) patients persisted through one year following a single intravitreal injection in...

6/18/2021
BreakingClinical TrialGlaucomaPharma
Glaukos Completes Enrollment in US Phase III Trials for iDose Travoprost Implant
Glaukos Completes Enrollment in US Phase III Trials for iDose Travoprost Implant

Glaukos announced June 10 that it had completed enrollment and randomization in its US FDA Phase III clinical trials for the iDose TR sustained-release travoprost implant. Two double-masked trials ...

6/18/2021
BreakingDeviceGlaucomaRegulation
PreserFlo MicroShunt for Glaucoma Gains Approval in Australia
PreserFlo MicroShunt for Glaucoma Gains Approval in Australia

Glaukos announced June 8 that Australia’s Therapeutic Goods Administration (TGA) had granted regulatory approval for the PreserFlo MicroShunt. The PreserFlo is an ab externo drainage system that re...

6/18/2021
BreakingFundingPharmaRetina
Molecular Partners Launches $63.8 Million IPO to Advance DARPin Technology
Molecular Partners Launches $63.8 Million IPO to Advance DARPin Technology

Swiss company Molecular Partners announced June 16 the pricing of a $63.8 million initial public offering in the US of 3 million American Depositary Shares at a public offering price of $21.25 per ...

6/18/2021
BreakingDealsPharma
Oyster Point, APT to Collaborate on Ophthalmic Treatments for Drug-Resistant Infections
Oyster Point, APT to Collaborate on Ophthalmic Treatments for Drug-Resistant Infections

Oyster Point Pharma, of Princeton, New Jersey, announced June 10 that it had formed a research collaboration with Adaptive Phage Therapeutics (APT) to leverage APT’s PhageBank technology for the de...

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

United States
US Surveys
May select more than one